tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Xeris Pharmaceuticals: Strong Financial Performance and Strategic Growth Drive Buy Rating
PremiumRatingsXeris Pharmaceuticals: Strong Financial Performance and Strategic Growth Drive Buy Rating
2M ago
Xeris Biopharma price target raised to $7 from $6 at Oppenheimer
Premium
The Fly
Xeris Biopharma price target raised to $7 from $6 at Oppenheimer
2M ago
Xeris Biopharma Reports Strong Q1 2025 Growth
Premium
Company Announcements
Xeris Biopharma Reports Strong Q1 2025 Growth
2M ago
Xeris Biopharma (XERS) Expects to Ride the Wave of 30% Revenue Growth in 2025
PremiumMarket NewsXeris Biopharma (XERS) Expects to Ride the Wave of 30% Revenue Growth in 2025
4M ago
Xeris Biopharma’s Earnings Call Highlights Growth and Optimism
Premium
Company Announcements
Xeris Biopharma’s Earnings Call Highlights Growth and Optimism
4M ago
Xeris Biopharma price target raised to $6 from $5 at Leerink
Premium
The Fly
Xeris Biopharma price target raised to $6 from $5 at Leerink
4M ago
Xeris Biopharma Reports Record Revenue and Strong 2025 Outlook
PremiumCompany AnnouncementsXeris Biopharma Reports Record Revenue and Strong 2025 Outlook
4M ago
Xeris Biopharma files $250M mixed securities shelf
Premium
The Fly
Xeris Biopharma files $250M mixed securities shelf
4M ago
Xeris Biopharma reports Q4 EPS (3c), consensus (2c)
Premium
The Fly
Xeris Biopharma reports Q4 EPS (3c), consensus (2c)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100